PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CAMK2A 42 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Anakinra (Kineret)- FDA 10 Drug Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
Sodium Channel Nav1.8 31 Target Disease Infection 766,637 1 0.00 -0.98 0.03 0.53
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
Artemin 184 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.49
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Retinoic Acid Receptor Gamma-1 6 Target Disease Infection 766,637 1 0.00 -0.91 0.17 0.55
Pneumonia Pneumocystis Carinii 3 Disease Disease Infection 766,637 1 0.00 -0.82 0.33 0.56
Alpha (Prolastin)- FDA 13 Drug Disease Infection 766,637 1 0.00 -0.96 0.08 0.54
Epigen 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Carcinoma Bladder 25 Disease Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Glutathione S-Transferase Theta-1 70 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
Acute Migraine 946 Disease Disease Infection 766,637 1 0.00 -1.00 0.00 0.46
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Hepatitis Chronic Active 6 Disease Disease Infection 766,637 1 0.00 -0.91 0.17 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.50
High Affinity Nerve Growth Factor Receptor 47 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Phosphodiesterase 4b 54 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Extrapyramidal Disorder 81 Disease Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
Aurora B kinase 415 Target Disease Infection 766,637 2 0.00 -1.00 0.00 0.49
BAFFR 44 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
Chorismate Synthase 85 Target Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
Aralen (Chloroquine)- FDA 19 Drug Disease Infection 766,637 2 0.00 -0.95 0.11 0.55
Ambisome (Amphotericin B)- FDA 7 Drug Disease Infection 766,637 2 0.00 -0.85 0.29 0.56
Carcinoma Squamous Cell 47 Disease Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
Dopamine Receptor D3 45 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
EPHA4 357 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.49
N-Type Calcium Channel 453 Target Disease Infection 766,637 2 0.00 -1.00 0.00 0.49
Doxylamine 206 Drug Disease Infection 766,637 3 0.00 -0.99 0.01 0.51
DDR2 194 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.51
Cytokeratin 20 847 Target Disease Infection 766,637 3 0.00 -1.00 0.00 0.48
D4-GDI 35 Target Disease Infection 766,637 3 0.00 -0.96 0.09 0.54
Avastin (Bevacizumab)- FDA 207 Drug Disease Infection 766,637 3 0.00 -0.99 0.01 0.51
CCNB1 160 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
ENO2 87 Target Disease Infection 766,637 3 0.00 -0.98 0.03 0.53
Parkinsons Disease 124 Disease Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Infection Soft Tissue 3 Disease Disease Infection 766,637 3 0.00 -0.50 1.00 0.58
A1M 59 Target Disease Infection 766,637 3 0.00 -0.97 0.05 0.54
Arthralgia Syndrome 23 Disease Disease Infection 766,637 3 0.00 -0.93 0.13 0.55
FABP3 134 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
APOH 110 Target Disease Infection 766,637 4 0.00 -0.98 0.04 0.53